ZANAGLIO, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.120
EU - Europa 441
AS - Asia 181
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 1.749
Nazione #
US - Stati Uniti d'America 1.109
IT - Italia 164
CN - Cina 101
UA - Ucraina 92
DE - Germania 52
FI - Finlandia 31
HK - Hong Kong 28
IE - Irlanda 28
SG - Singapore 27
SE - Svezia 23
GB - Regno Unito 17
CZ - Repubblica Ceca 15
IN - India 12
CA - Canada 10
BE - Belgio 8
FR - Francia 6
TR - Turchia 5
AU - Australia 2
BR - Brasile 2
GR - Grecia 2
JP - Giappone 2
MY - Malesia 2
EG - Egitto 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
RU - Federazione Russa 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.749
Città #
Fairfield 193
Chandler 107
Ashburn 87
Jacksonville 75
Seattle 72
Woodbridge 70
Wilmington 69
Ann Arbor 66
Cambridge 54
Houston 51
Princeton 51
New York 47
Beijing 39
Brescia 32
Helsinki 31
Hong Kong 28
Dublin 26
Shanghai 18
Boardman 15
Brno 14
Singapore 13
Des Moines 12
Pune 11
Nanjing 9
Brussels 8
Shenyang 7
Toronto 7
Genoa 6
Jinan 6
San Diego 6
Bosio 5
Darfo 5
Kocaeli 5
Rome 5
Battipaglia 4
London 4
Milan 4
Tianjin 4
Alzano Lombardo 3
Bergamo 3
Bologna 3
Brendola 3
Dearborn 3
Viterbo 3
Ancona 2
Casanova Lonati 2
Castleknock 2
Changsha 2
Chiswick 2
Guangzhou 2
Hebei 2
Lovere 2
Melbourne 2
Ningbo 2
Nocera Superiore 2
Padova 2
Pescara 2
Shah Alam 2
São Paulo 2
Tokyo 2
Vicenza 2
Amman 1
Athens 1
Augusta 1
Brooklyn 1
Castiglione Delle Stiviere 1
Catania 1
Centurion 1
Chicago 1
Chieti 1
Civitavecchia 1
Falkenstein 1
Fiorenzuola D'arda 1
Gossolengo 1
Gîza 1
Haikou 1
Hangzhou 1
Hanover 1
Jiaxing 1
Kilburn 1
Kish 1
Kunming 1
La Spezia 1
Leawood 1
Lequio Tanaro 1
Los Angeles 1
Mcallen 1
Mexico City 1
Munich 1
Nanchang 1
Nanterre 1
New Bedfont 1
North York 1
Norwalk 1
Olomouc 1
Orange 1
Pesaro 1
Porto 1
Redwood City 1
Riga 1
Totale 1.357
Nome #
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 117
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 115
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 105
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 103
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 95
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 95
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 82
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 80
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 79
Advances in CMV Management: A Single Center Real-Life Experience 76
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 75
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 66
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 65
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 62
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 62
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 61
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 58
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 56
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 54
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 47
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 46
dsDNA from extracellular vesicles (EVs) in adult AML 45
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 43
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 40
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 40
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 27
Totale 1.794
Categoria #
all - tutte 10.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020324 14 2 4 12 18 28 25 29 51 78 27 36
2020/2021555 14 32 19 95 30 77 29 60 52 77 40 30
2021/2022265 21 15 3 26 14 25 11 20 14 45 16 55
2022/2023292 38 15 12 20 22 54 2 49 44 7 16 13
2023/2024308 17 4 35 16 19 85 11 9 46 1 4 61
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.794